Tuesday, March 31, 2009

What a great conference!

We've had a great time in San Diego at the 2009 IACUC Conference, and wanted to share a few of our favorite moments.

Day one kicked off with the Henry Spira Memorial Lecture, Improving the Treatment of Animals: A Practical Perspective, delivered by Temple Grandin. (Read more about this lecture in
yesterday's blog post.)

Immediately following Dr. Grandin’s speech was Panel I: Conflicts of Interest. (Suzanne Rivera, associate vice president of research services at UT Southwestern Medical Center, is pictured here.)

After a book signing with Dr. Grandin, attendees headed to the Networking Luncheon, where colored balloons corresponded to job titles, so that people with similar responsibilities and concerns could share their experiences.

Later that afternoon was the Living Room Conversation a round-table discussion of performance and engineering standards in animal care and use. The panel reviewed case studies in a “living room style” format. (Chris Newcomer, John Young, and Cathy Liss are pictured here. Not pictured: Moderator Andy Rowan, and panelists Larry Carbone and John McGlone.)

They learned. They shared. They connected. The breakout sessions are often described as the “meat” of the conference, and this year was no exception. During 40 concurrent sessions on Monday, attendees swapped new ideas and best practices in hopes of improving their animal care and use programs.

We hope everyone had a great time at the 2009 IACUC Conference! Safe travels home and we'll see you in Baltimore, MD, for the 2010 IACUC Conference, March 22-23, 2010, with pre-conference programs on March 21.
(We'll post more pictures soon on our Flickr site!)

Monday, March 30, 2009

Greetings from San Diego, and the Henry Spira Memorial Lecture

By Anne Meade, web and distance education coordinator

This morning, the 2009 IACUC Conference began with the Eighth Annual Henry Spira Memorial Lecture. Henry Spira, ethicist, social justice advocate, and animal rights activist, is recognized at PRIM&R’s IACUC Conference for his ability to bring together those within the scientific and animal welfare communities who have often faced each other across a seemingly unbridgeable divide. This year’s lecture, Improving the Treatment of Animals: A Practical Perspective, was delivered by Temple Grandin.

She discussed her work in the livestock industry on facility design, handling, and animal welfare. Speaking to more than 600 IACUC professionals, she focused on two things: why those involved with animal research need to communicate the importance of their research, and the impact management has on the stress level of the animals being treated.

Although the livestock and animal research industries are both criticized, Dr. Grandin suggested that those who are reacting are not doing so correctly. “You need to show what you do in the lab so that those in the outside world have a better understanding,” she noted.

Dr. Grandin also explained how important it is for those who deal with animals, either in the laboratory or in the slaughterhouse, to be trained on how animals will react to situations. “The normal human mind drops the detail,” Dr. Grandin said, “but the animal’s mind is a mind of detail.”

Small changes to lighting or restraint technique, for example, could make a big difference in how well the animal cooperates. Dr. Grandin closed her talk by suggesting that more focus be put on improving management than adopting new technologies. “The attitude of the management is the single biggest factor that determines how animals are treated.”

PRIM&R was thrilled to feature Dr. Grandin and her important message during the conference. For those interested in learning more about Dr. Grandin, please visit her website.

Saturday, March 28, 2009

Day 1 at the 2009 IACUC Conference - Pre-Conference Programs

Today, we started off the 2009 IACUC Conference in beautiful San Diego by offering two pre-conference programs: IACUC 101 and IBC Basics. Together, these courses gathered together nearly 160 research professionals from around the globe and addressed critical issues in both IACUC administration and IBC management. As with all PRIM&R meetings, the hallmarks of the day were quality learning and information sharing, as well as always helpful networking.

We’re looking forward to Sunday’s session—the AAALAC International Conference on Quality Animal Care. This meeting, held once every four to five years, will feature critical information gathered from the past several years of AAALAC International site visits. Attendees will…


  • Understand current trends and AAALAC International expectations for quality research animal care and use.
  • Appreciate the most frequently observed concerns reported by AAALAC site visitors over the last five years.
  • Learn of potential solutions and successful case studies.

PRIM&R is thrilled to offer the 2009 IACUC Conference in conjunction with AAALAC International’s meeting, and is grateful to all of the attendees who have traveled far and wide to San Diego for the meeting. In these economic times, we understand how challenging it can be to secure both the time and money for professional development and professional connections. We appreciate that the nearly 660 people who will be attending the meeting have selected to come to PRIM&R, and look forward to telling you more about the conference in the coming days.

Thursday, March 26, 2009

TN Med School Moves to Eliminate Ethics Department

Posted on the IRB Forum
March 1, 2009

To our colleagues in bioethics:

We need your help. We need you to write letters, and we need it fast.

Here at the University of Tennessee medical school, the Dean has informed us that he intends to eliminate our entire department. Last summer he informed our chair, Dr. Terry Ackerman, that he wanted to do this, and now the machinery to effect his plan is in motion.

Earlier today the UT Board of Trustees approved a revised policy for "discontinuing academic units," thereby activating the process in earnest.


A final decision about us will ultimately require the approval of the Chancellor at this campus, the President of UT, and finally the Board of Trustees.

UT's medical ethics department ("Human Values and Ethics") is one of the oldest in the country. It began as a program in the mid-'70s and became a full-fledged department of the medical school in the mid-'80s. All three of us (Terry Ackerman, Carson Strong and Haavi Morreim) are tenured at the rank of professor and, other than "for cause," the only way that tenured faculty can be removed is if their positions are eliminated.

Here are the dean's exact and complete words, as communicated to the Trustees, for including our department in his list of units to be
discontinued:

"Primary goals of this department are to teach and do research to increase awareness of ethical and moral issues associated with healthcare. Human Values & Ethics, with 3 tenured faculty, is under consideration for discontinuation as it has minimal funded research programs and limited teaching of medical students. Training of human values and ethics is necessary in medical school; however this will continue to be done primarily by experienced physicians as students go through clinical rotations. Immediate plans call for retaining one faculty at half-time to coordinate this training. Long-term effects of discontinuance on UT and the State of Tennessee are anticipated to be minimal."

First problem: the Dean's proposed alternative is a clear violation of LCME standards (Liaison Committee on Medical Education) for accrediting medical schools. In ED-23 and ED-17A (http://www.lcme.org/functions2008jun.pdf), LCME requires that students receive ethics instruction in preclinical years, and *formally* during clinical rotations. The dean's plan eliminates preclinical instruction and provides only informal teaching during clinical rotations. To our knowledge, there are no MDs or other PhDs who have any advanced qualifications in ethics at this institution.

Second problem: contrary to the Dean's statement, our primary goal is not merely to "increase awareness." We co-teach a required course for the first- and second-year students that has a major ethics component; conduct seminars for third-year students rotating through pediatrics and ob/gyn; and participate extensively in clinical teaching during regular patient-focused rounds and conferences for such departments as pediatrics, ob/gyn, and internal medicine. We also have a substantial involvement in teaching residents.

Third problem: the dean's comment on research does not discuss the quality of our work, only its lack of extramural funding. We have informed him that funding for research in bioethics is very limited, particularly as compared to the monies available for medical research; also, that much of what is available is directed toward social science exploration of topics of relevance to ethics (e.g. empirical studies of informed consent), rather than the more purely philosophical and ethics-oriented research that this department has historically produced.

We ask you to write letters to the Chancellor, to the President and to the Trustees. Their names and addresses are just below‹one letter will do it for all the Trustees. We have known our campus' Chancellor, Dr. Pat Wall, to be a fine human being with a strong sense of value and priorities. He is no moral coward. We believe he in particular will take seriously your thoughtful expressions. Letters to the President and Trustees will provide him with important reinforcement.

The content of the letter can be the same for each recipient, but:

  • sending one letter to one person will not be as helpful as sending that letter to all three (Chancellor, President, Trustees);
  • sending one letter from a department/program as a whole is good, but not nearly as good as if each willing member of the department sends letters.

We would deeply appreciate an earnest letter explaining why saving money by eliminating ethics is unwise for a medical school. It would also be helpful to comment on our national reputations, as that is one of the factors to be considered.

Please help. We send our heartfelt thanks to you all.

Terry Ackerman
Carson Strong
Haavi Morreim

========================================

Chancellor:
Pat Wall, M.D.
Chancellor, UTHSC
409 Hyman Administration Building
University of Tennessee Health Science Center Memphis, TN 38163

President:
Jan Simek, Ph.D.
Interim President, University of Tennessee Office of the President
831 Andy Holt Tower
University of Tennessee
Knoxville, TN 37996-0180

Trustees:
You can use one letter for all trustees. When your letter is received in the Trustees' office, they'll scan it an e-mail it to all members.

Address:
Board of Trustees Office
University of Tennessee
719 Andy Holt Tower
Knoxville TN 37996-0170

If you wish to do so, it would be helpful to us if you would send a copy of your letter to:
Dr. Terrence F. Ackerman
Chair, Dept. of Human Values and Ethics
910 Madison Avenue, Suite 311
University of Tennessee Health Science Center Memphis TN 38163

Wednesday, March 25, 2009

Hearing on “Institutional Review Boards that Oversee Experimental Human Testing for Profit”

Even though this hearing will take place in Washington, D.C., there's also a webcam option so anyone who is interested can "attend."

Energy and Commerce Subcommittee Hearing on “Institutional Review Boards that Oversee Experimental Human Testing for Profit”

The Subcommittee on Oversight and Investigations will hold a hearing titled, “Institutional Review Boards that Oversee Experimental Human Testing for Profit” at 10:00 a.m. on Thursday, March 26, 2009, in 2123 Rayburn House Office Building in Washington, D.C. The hearing will examine whether institutional review boards (IRBs) and the federal government are adequately protecting human subjects of biomedical research.


Witness List
  • Gregory Kutz, Managing Director, Forensic Audits and Special Investigations, Government Accountability Office
  • Dr. Jerry Menikoff, Director, Office for Human Research Protections, Department of Health and Human Services
  • Dr. Joanne Less, Director, Good Clinical Practice Program, Food and Drug Administration
    Daniel Dueber, Chief Executive Officer, Coast IRB, LLC

See it on webcam if you go to the Committee’s website, at http://energycommerce.house.gov/index.php?option=com_content&task=view&id=1507&Itemid=106.

Tuesday, March 24, 2009

We’re almost there…

..and it's almost here!

Of course, I'm talking about the 2009 IACUC Conference, which is set to kick off in just four days at the Town and Country Resort & Convention Center in San Diego, CA. Some PRIM&R staff members head to San Diego today to finalize the last of the details before the conference kicks off with our pre-conference programs on March 28.

For those of you heading to the conference, we wanted to take a moment to answer a few outstanding questions you might have:

  1. Where and when is registration check-in?
    Registration check-in will take place in the Atlas Foyer at the following times:

    Friday, 4:00–6:00 PM
    Saturday, 7:00 AM–6:00 PM
    Sunday, 7:00 AM–6:00 PM
    Monday, 7:00 AM–6:00 PM
    Tuesday, 7:00 AM–2:00 PM


  2. What should I pack?
    As an attendee, we encourage you to wear comfortable, casual clothing throughout the meeting. We’re expecting (for now!) sunny weather, with temperatures in the 60s.


  3. How do I get from the airport to the Town and Country?
    Conference attendees can take ground transportation to and from San Diego International Airport and the Town and Country, for $10.00 each way by using Express Shuttle. Learn more about how to make a reservation and download a coupon here
    .

  4. What should I do in my downtime?
    If you find yourself with a few free minutes on Monday or Tuesday, be sure to take the time to visit our Poster Presentations
    (located in the Atlas Foyer), as well as our exhibitors (located in the Golden Ballroom Foyer). Or stop by the PRIM&R booth in the Atlas Foyer to learn more about PRIM&R, CPIA, or to enter to win a PRIM&R membership!

  5. Where can I find the PRIM&R staff if I need them?
    Some of our staff will be relocating to the Town and Country, but others will remain at the office. We are all available to answer questions that you may have. If you need to reach our on-site office, please call 619.291.7131 and ask to be connected to the PRIM&R office. If, for any reason, the hotel doesn't answer, you can still call our Boston office at 617.423.4112, from 9:00 AM to 5:00 PM ET and someone will happily assist you.

See (some of) you in San Diego!

Friday, March 20, 2009

Join the conversation!

Recently, we invited people to contribute to the program development for the 2009 Advancing Ethical Research Conference. We recognize that feedback from the community is invaluable when it comes to gathering and fleshing out ideas, so we gave the option of posting ideas to the conference discussion forum.

Some fantastic ideas have been posted there, including:
  • Creating shorter consent forms with language appropriate for understanding by all educational levels and cultural backgrounds;

  • Cross-cultural differences in one's understanding of RCR issues;

  • Setting up committee reviews for stem cell research;

  • Nanotechnology and Medicine: Issues for Clinical Research;

  • and more!

We invite you to jump into the discussion forum and comment on these ideas, or post one of your own! (If you'd prefer, you can submit your idea using this online form.) The Conference Planning Committee will consider all posts and ideas that are submitted by March 24, but you can continue the conversation in our discussion forum long after that!

We’re grateful for your input, and we look forward to hearing from you soon.

Wednesday, March 18, 2009

Current Events

  • March 10 – Newsweek published a web-exclusive article about how social-networking sites created for physicians are becoming a benefit for drug manufacturers and investors.
  • March 12 – The New York Times reported on the undercover, apparent Congressional ‘sting,’ operation at Coast IRB related to a fraudulent medical device protocol sent from review. (Read the initial press release from Coast IRB here.)
  • March 12 – In Boston.com’s White Coat Notes blog, Steven Joffe, frequent PRIM&R contributor, commented, on a new poll of doctors who perform stem cell transplants that use cord blood cells, the results of which suggested storing a newborn baby's cord blood as a form of biological insurance against a future illness is rarely advisable.

Tuesday, March 17, 2009

Interview Excerpt: Hard Choices for IRBs: The IRB Third Wave

By Andrew Olmstead, director, member services and development, IRBNet

IRBNet, a frequent exhibitor at PRIM&R’s conferences, recently talked with Dr. Greg Koski about his views on critical issues IRBs face today. We have excerpted the beginning of their discussion here, but you can read the complete version by downloading the PDF at the bottom of the post. Please note that the inclusion of this article should not be construed as PRIM&R's endorsement of IRBNet or IRBNet's product.

CONTEXT: THE PAST 10 YEARS
Andrew Olmsted: For context, I’m going to describe two waves of change that have taken place in the world of IRBs and the management of the ethics review for humans. Wave one was… about years ago when we saw the proliferation of commercial IRBs coming into existence as an alternative to using local IRBs for review….

One outcome of the first wave is the number of commercial entities out there that make their living doing this—Western IRB being perhaps the oldest and most well known in the U.S.—but there are many others. The second wave I describe as the response from institutions… that have watched this change taking place, have considerable pressure on themselves to respond, and are trying to make decisions. And so it’s in this context that I was hoping we could chat. Is that a reasonable way to describe these waves?

Dr. Koski: Well, I think it’s fine to separate it into wave one and wave two although there may have been many other waves, if not tsunamis and ripples, along the way. I think that in the first wave you described is largely accurate, although it began well more than 10 years ago.

The drivers were also a bit different than the way you characterized them. The independent IRBs basically grew largely out of the need for efficient review of studies that were not under the traditional institutional model that had been set up at or by NIH, HHS. These non-institutional IRBs instead were dealing with studies that were being reviewed and approved largely for industry, corporate sponsored studies that were primarily under FDA oversight rather than…OHRP oversight. In fact, the so-called private or independent IRBs (hopefully all IRBs are independent), the private and often for profit IRBs, were focused primarily on reviewing this industrially sponsored clinical research or other private sponsored research that did not have U.S. government support or funding and therefore came under a different set of regulations.

There’s a slight difference there but indeed, as history progressed, we found that when institutional IRBs actually began to get into trouble or recognized shortcomings in their own processes, institutions did begin, as you said, to turn to some of these independent IRBs in order to supplement what could be provided within the institution by its own structure and resources….

For the full-text version of this interview, please download it here.

Monday, March 16, 2009

Who was wearing their dancing shoes?

Here's the newest Monday Memory. Do you remember doing the YMCA at this event centered on human subjects protections? Before we dive back into our archives, please let us know: Were you there? What other 'tunes did you dance to?

As part of our 35th anniversary, we'd like to remind you (and ourselves) of PRIM&R's journey, so we will periodically post interesting photos and ask that YOU to jog our memories and fill in the details.

Friday, March 13, 2009

Happy Anniversary to PRIM&R!

Posted by Joan Rachlin, executive director

Now that our year-long 35th anniversary celebration is officially underway, I wanted to share with you some milestones in PRIM&R’s history, including an account of its founding that was written by Neil Chayet, a Boston-based attorney who was the moving force behind the organization’s creation.

Neil captured those early years in great detail and with great gusto, and for those history buffs among you who are interested in finding out what those post-1974 years were like, I refer you to Sandy Chodosh “Reflections on My 20 Years With PRIM&R".

Sandy also prepared a timeline which highlights many of the watershed moments over the past three and a half decades. Among the peaks cited are:

1974 – PRIM&R is incorporated!
1977 – First PRIM&R “Protection of Human Subjects/IRB” conference
1977 – First edition of the PRIM&R newsletter
1977 – Gwen O’Sullivan, a then PRIM&R Board member, suggests to the National Commission a system for accrediting IRBs
1978 – Board proposes that PRIM&R become a national organization
1980 – The President’s Commission contracts with PRIM&R to work on a guidebook for IRBs
1981 – First PRIM&R conference outside of Boston is held in Asilomar, CA
1982 – The Office for Protection from Research Risks (OPRR), under Charlie McCarthy’s leadership, collaborates with PRIM&R on a series of one day conferences around the country
1983 – The PRIM&R Board begins planning first animal care and use conference
1984 – Board member Natalie Reatig suggests that PRIM&R form a national association for IRBs
1985 – Board members Natalie Reatig and Barbara Stanley are authorized to develop a plan to form a national association for IRBs within PRIM&R; David Bernhardt suggests that it be named “Applied Research Ethics National Association (ARENA)”
1986 – PRIM&R and UTHSC host meeting in Houston celebrating the 20th anniversary of IRBs
1986 – ARENA launches, and Barbara Stanley is the first Council President
1986 – IACUC Guidebook prepared and published by ARENA
1988 – PRIM&R holds a conference on HIV/AIDS with C. Everett Koop as keynote speaker
1990 – PRIM&R sponsors a conference on conflicts of interest in conjunction with Massachusetts General Hospital
1991 – PRIM&R “breaks even” for the first time in its history!
1991 – PRIM&R holds a conference on ethics committees
1992 – ARENA has 500 members!
1993 – PRIM&R forms a consortium called the National Educational Alliance in the Life Sciences (NEALS) to bring all those working in the animal research field into an umbrella organization
1994 – PRIM&R holds its first of six conferences on the responsible conduct of research
1995 – PRIM&R holds the first conference in San Diego, and attracts over 600 attendees
1996 – AAMC provides the technical support for the creation and launch of a PRIM&R/ARENA website
1996 – ARENA begins to explore certification for IRB administrators/professionals
1997 – PRIM&R staff begin using e-mail
1998 – PRIM&R holds a conference on central review boards
1999 – Jesse Gelsinger dies in a gene transfer study at U Penn
1999 – PRIM&R’s 25th Anniversary celebrated
1999 – The PRIMR& Board endorses the concepts of certification for IRB administrators and accreditation for institutions conducting human subjects research.
2000 – Administration of the first certification test for IRB professionals (CIP)
2001 – Jay Katz Receives 1st PRIM&R Lifetime Achievement Award
2001 – AAHRPP is organized as an independent organization
2002 – PRIM&R staff triples in size, growing from 3 to 9
2002 – ARENA has more then 2,000 members
2003 – Charles McCarthy receives the second PRIM&R Lifetime Achievement Award
2004 – PRIM&R turns 30!
2006 – ARENA is officially retired, and PRIM&R formally becomes an organization with members
2007 – PRIM&R offers the first certification test for animal care and use professionals: CPIA
2008 – PRIM&R exceeds 3,300 members
2009 – PRIM&R turns 35!

Thank you for joining us on this organizational path. It would be a lonely journey without our community alongside, and we look forward with optimism and great gratitude to the next 35 years.

Wednesday, March 11, 2009

Current Events – March 9–11

It’s been a busy week in the world of research ethics, and we wanted to take a minute to provide you with a list of a few news outlets where you can find out more about these current events.

On Monday, President Obama signed an executive order to lift the ban on embryonic stem cell research.


  • The New York Times provided a “News Analysis” on the subject;
  • Blogger Nancy Walton (The Research Ethics Blog) wrote an excellent overview of what this means to for research; and
  • CNN commented on President Obama’s move to “separate politics and science.”

Then, on Tuesday, it was alleged that Scott S. Reuben, a Massachusetts anesthesiologist, fabricated 21 medical studies, some of which were funded by Pfizer, involving major drugs.

  • Anesthesiology News first reported the retractions of the studies from several anesthesiology journals;
  • The Wall Street Journal provided a brief overview of the story in their Health Blog; and
  • WBUR, Boston's NPR station, invited Jerome Kassirer, former New England Journal of Medicine editor, to speak on their program this morning (interview available via RealAudio).

Finally, today it was reported that the Obama administration has determined a leading candidate to fill two top posts at the FDA.

  • The Wall Street Journal reported that the Margaret "Peggy" Hamburg is the leading candidate to become FDA commissioner, while Baltimore health chief Joshua Sharfstein is in line to become a deputy commissioner.
  • In addition, the Wall Street Journal Health Blog provided a bit more information about Dr. Hamburg.

Photo credits: Ron Edmonds, AP (Obama); U.S. National Library of Medicine, National Institutes of Health (Hamburg)

Tuesday, March 10, 2009

Request for information and comments on IRB accountability

The Office for Human Research Protections (OHRP), has issued a Federal Register notice requesting information and comments from the public about whether the office should pursue a notice of proposed rulemaking to enable OHRP to hold IRBs and the institutions or organizations operating the IRBs directly accountable for meeting certain regulatory requirements of 45 CFR part 46. OHRP is contemplating this regulatory change to encourage institutions to rely on IRBs that are operated by another institution or organization, when appropriate. OHRP believes that such a regulatory change in its enforcement authority may address one of the main disincentives institutions have cited as inhibiting them from exercising the regulatory flexibility that currently permits institutions to implement a variety of cooperative review arrangements and to rely on the review of an IRB operated by another institution or organization. If institutions become more willing to rely on cooperative review arrangements and on review of IRBs operated by other institutions or organizations, OHRP believes that this will reduce administrative burdens associated with implementing 45 CFR part 46 without diminishing human subject protections.

This request for information and comments stems from interest in this issue from the Secretary's Advisory Committee on Human Research Protections and others, as well as two meetings on alternative IRB models that OHRP co-sponsored in November 2005 and November 2006 along with the National Institutes of Health, the Association of American Medical Colleges, and the American Society of Clinical Oncology.

Submit written or electronic information and comments by June 3, 2009. Written comments may be sent to IRB ACCOUNTABILITY, Office for Human Research Protections, The Tower Building, 1101 Wootton Parkway, Suite 200, Rockville, MD 20852. Comments also may be sent via e-mail to IRBaccountability@hhs.gov, or via facsimile at 301.402.2071.

Comments received within the comment period, including any personal information provided, will be made available to the public upon request.

The notice can be accessed at: http://edocket.access.gpo.gov/2009/E9-4628.htm or http://edocket.access.gpo.gov/2009/pdf/E9-4628.pdf.

Monday, March 9, 2009

Get Involved at the 2009 IACUC Conference

Posted by Joanna Cardinal, membership manager

Hello again everyone! My first two months at PRIM&R have been a whirlwind as we have been busy preparing for the upcoming 2009 IACUC Conference. I wanted to slow down long enough to let you know about some of the ways you may get involved in this event.

If you’re new to PRIM&R, curious about the benefits of membership, or are looking to connect with your fellow members, please join me Tuesday, March 31, from 7:30–8:30 AM for the Membership Orientation and Continental Breakfast. Start your day off right with an overview of membership benefits, a chance to ask questions, and coffee!!! Just let me know you’re coming and I’ll be sure to save you a seat (all are welcome to attend).

Do you have questions about animal welfare, IACUC operations, or regulations? Register now and take advantage of our very popular Speed Networking event on Monday, March 30, from 5:45–7:00 PM. I know you’ll enjoy having your questions answered by our distinguished mentors. After you’ve gotten a taste of mentoring, I encourage you to get involved with the PRIM&R Mentoring Program as either a mentor (pay it forward!) or a mentee.

Finally, PRIM&R conferences would not be successful without your help. If you haven’t done so already, please peruse our volunteer opportunities and make the most of your 2009 IACUC Conference experience.

For more information on these and other special events at the conference, please visit our website.

We strive to make sure you are satisfied with the benefits of PRIM&R membership. If you have any questions, comments, or suggestions please stop by the help desk at the conference and let me know. If you won’t be attending the conference you can always e-mail or call me at 617.423.4112, ext. 16.

I’m really looking forward to meeting you later this month!

Thursday, March 5, 2009

January Webinar Recap

Posted by Anne Meade, web and distance education coordinator

On Thursday, January 29, 2009, PRIM&R held a webinar titled Refocusing on IRB’s Crucial Issues: New Year, New Lens. This 90-minute session was presented by Bruce Gordon, MD, chairman of the IRB and professor of Pediatrics at University of Nebraska Medical Center, and Moira Keane, MA, director of the University of Minnesota Research Subjects’ Protection Programs. Ms. Keane and Dr. Gordon presented information on how to take advantage of the flexibility provided in the federal regulations for managing human subjects research programs while maintaining the highest ethical and regulatory standards.

PRIM&R members can read this recap in its entirety here (members only)
.

To learn more about accessing the archive of this program, or about any of our past or future webinars, please contact me
.

Tuesday, March 3, 2009

In February’s Newsletter…

The most recent issue of the PRIM&R Newsletter (members only) was distributed on Friday, February 27.

In addition to our regular features, such as Recent Headlines, Government and Legal News, and Public Policy
, this issue included…
  • An invitation for 2009 IACUC Conference attendees to register for the Speed Mentoring event;
  • A featured talk from PRIM&R Through the Years, a 532-page compilation of presentations delivered by internationally esteemed experts in the field of research ethics at PRIM&R's past annual meetings. This month feature is Stanley Milgram’s speech, “The Role of Deception in Research,” which he gave in October 1979 at PRIM&R’s Behavioral and Social Science Research and the Protection of Human Subjects meeting;
  • A PRIM&R membership Benefit Spotlight highlighting complimentary access to Collaborative Institutional Training Initiative (CITI);
  • A recap of the January 29 webinar, Refocusing on Crucial Issues for IRBs: New Year, New Lens; and
  • Our Website Feature of the Month, which highlighted how to print out receipts for membership and conference transactions.

Can’t find the Newsletter in your inbox? Check out the Newsletter Archives.

Want to become a PRIM&R member? Learn more.